Seung Min Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Seung Min Kim has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Bum Joon Kim
Department of Neurology, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, Korea
5 shared publications Heewon Bae
3 shared publicationsInha Hwang
2 shared publicationsJeong Seob Kim
Department of Neurology, Veterans Health Service Medical Center, Seoul, Korea
2 shared publications- Sang Hee Ha
Department of Neurology, Gil Medical Center, Gachon University, College of Medicine, Incheon, Korea
2 shared publications Sang Won Ha
Department of Neurology, Veterans Health Service Medical Center, Seoul, Korea
2 shared publications
Latest Publications
- 1 November 2026
- Published by Korean Neurological Association in Journal of the Korean Neurological Association
- Vol. 44 (4) , 373-374
Isolated Enlargement of the Inferior Rectus Muscle Associated with Thyroid Eye Disease
- 1 November 2026
- Published by Korean Neurological Association in Journal of the Korean Neurological Association
- Vol. 44 (4) , 373-374
Isolated Enlargement of the Inferior Rectus Muscle Associated with Thyroid Eye Disease
- Open Access
- 31 October 2026
- Published by Korean Society of Cardiovascular Disease Prevention in Cardiovascular Prevention and Pharmacotherapy
- Vol. 8 (4) , 89-100
Tenecteplase for acute ischemic stroke: from an alteplase alternative toward workflow-oriented thrombolysis
Tenecteplase has emerged as a practical, evidence-supported thrombolytic alternative for acute ischemic stroke, challenging the long-standing predominance of alteplase. Greater fibrin specificity, resistance to plasminogen activator inhibitor-1, a longer half-life, and single-bolus administration provide a strong pharmacologic rationale for its use in time-sensitive stroke care. Accumulating evidence from randomized trials and meta-analyses suggests that tenecteplase 0.25 mg/kg is a reasonable alternative to alteplase for eligible patients treated within 4.5 hours, with particular practical advantages for those with large vessel occlusion who may require transfer for endovascular thrombectomy. Recent trials have broadened the discussion to include imaging-selected treatment beyond the conventional time window and adjunctive intra-arterial administration after thrombectomy. However, implementation varies across regions, and regulatory approval, reimbursement, safety concerns, and limited real-world data from Asia continue to shape clinical adoption. This review examines the pharmacologic rationale, clinical trial evidence, evolving guidelines, workflow implications, and unresolved questions surrounding tenecteplase for acute ischemic stroke, focusing on its potential role in Asian stroke systems.
- 31 October 2026
- Published by Korean Society of Cardiovascular Disease Prevention in Cardiovascular Prevention and Pharmacotherapy
- Vol. 8 (4) , 89-100
Open AccessTenecteplase for acute ischemic stroke: from an alteplase alternative toward workflow-oriented thrombolysis
Tenecteplase has emerged as a practical, evidence-supported thrombolytic alternative for acute ischemic stroke, challenging the long-standing predominance of alteplase. Greater fibrin specificity, resistance to plasminogen activator inhibitor-1, a longer half-life, and single-bolus administration provide a strong pharmacologic rationale for its use in time-sensitive stroke care. Accumulating evidence from randomized trials and meta-analyses suggests that tenecteplase 0.25 mg/kg is a reasonable alternative to alteplase for eligible patients treated within 4.5 hours, with particular practical advantages for those with large vessel occlusion who may require transfer for endovascular thrombectomy. Recent trials have broadened the discussion to include imaging-selected treatment beyond the conventional time window and adjunctive intra-arterial administration after thrombectomy. However, implementation varies across regions, and regulatory approval, reimbursement, safety concerns, and limited real-world data from Asia continue to shape clinical adoption. This review examines the pharmacologic rationale, clinical trial evidence, evolving guidelines, workflow implications, and unresolved questions surrounding tenecteplase for acute ischemic stroke, focusing on its potential role in Asian stroke systems.
- Open Access
- 1 August 2026
- Published by Korean Neurological Association in Journal of the Korean Neurological Association
- Vol. 44 (3) , 244-245
Painful Oculomotor Nerve Palsy Caused by a Newly Detected Posterior Communicating Artery Aneurysm
- 1 August 2026
- Published by Korean Neurological Association in Journal of the Korean Neurological Association
- Vol. 44 (3) , 244-245
Open AccessPainful Oculomotor Nerve Palsy Caused by a Newly Detected Posterior Communicating Artery Aneurysm
- Open Access
- 15 January 2026
- Published by Oxford University Press (OUP) in Journal of Sickle Cell Disease
- Vol. 3 (1) , yoag015
Cerebral microhemorrhages in a mouse model of sickle cell disease
Objectives: Stroke in sickle cell disease (SCD) is often attributed to large vessel involvement in the disorder, whereas the contribution of cerebral microvascular disease has been less explored. In this study, we investigated the formation of cerebral microvascular lesions and the involvement of mast cells in a humanized SCD mouse model. Methods: We studied hemorrhagic microvascular disease in a well-characterized mouse model of humanized transgenic sickle (HbSS-BERK) expressing >99% human sickle hemoglobin (HbS) and a control (HbAA-BERK) mouse model expressing normal human hemoglobin A (HbA). Mouse brains were analyzed by Prussian blue staining to detect cerebral microhemorrhage (CMH) formation. Mast cell identification was performed by toluidine blue staining. Results: SCD brain sections exhibited approximately 86% more CMH than controls (mean ± SE of 1.17 ± 0.22 vs. 0.63 ± 0.13 number/cm2, P = .02). Mast cells were positively correlated with CMH number in SCD mice (Spearman r = 0.42, P < .05), but not in control mice. Conclusion: SCD mice demonstrated significantly increased CMH load compared with control mice, and SCD microhemorrhages were associated with the number of mast cells. These findings highlight the significance of cerebral microvascular disease in SCD and imply that cerebral mast cells may be a novel therapeutic target in SCD.
- 15 January 2026
- Published by Oxford University Press (OUP) in Journal of Sickle Cell Disease
- Vol. 3 (1) , yoag015
Open AccessCerebral microhemorrhages in a mouse model of sickle cell disease
Objectives: Stroke in sickle cell disease (SCD) is often attributed to large vessel involvement in the disorder, whereas the contribution of cerebral microvascular disease has been less explored. In this study, we investigated the formation of cerebral microvascular lesions and the involvement of mast cells in a humanized SCD mouse model. Methods: We studied hemorrhagic microvascular disease in a well-characterized mouse model of humanized transgenic sickle (HbSS-BERK) expressing >99% human sickle hemoglobin (HbS) and a control (HbAA-BERK) mouse model expressing normal human hemoglobin A (HbA). Mouse brains were analyzed by Prussian blue staining to detect cerebral microhemorrhage (CMH) formation. Mast cell identification was performed by toluidine blue staining. Results: SCD brain sections exhibited approximately 86% more CMH than controls (mean ± SE of 1.17 ± 0.22 vs. 0.63 ± 0.13 number/cm2, P = .02). Mast cells were positively correlated with CMH number in SCD mice (Spearman r = 0.42, P < .05), but not in control mice. Conclusion: SCD mice demonstrated significantly increased CMH load compared with control mice, and SCD microhemorrhages were associated with the number of mast cells. These findings highlight the significance of cerebral microvascular disease in SCD and imply that cerebral mast cells may be a novel therapeutic target in SCD.
- Open Access
- 19 March 2025
- Published by Wolters Kluwer Health in The Neurologist
- Vol. 30 (6) , 373-375
Unilateral Weakness Caused By Spinal Cord Infarction in a Renal Transplant Recipient
Introduction: Spinal cord infarction has various clinical presentations, depending on the vascular territory involved at the spinal cord level. The most common symptom is bilateral weakness. However, unilateral hemiparesis can occur if the sulcal artery is involved. Stroke is the most common and serious cerebrovascular complication associated with kidney transplantation. Clinically asymptomatic renal transplant recipients may experience increased intima-media thickening, which is significantly associated with an increased prevalence of cerebrovascular diseases. Case Report: Herein, we report the case of a 64-year-old adult male with a history of kidney transplantation who presented with sudden-onset right-sided hemiparesis. The patient presented with right shoulder pain, right fingertip paresthesia, and recent dysuria, necessitating catheterization. T2-weighted magnetic resonance imaging at the C2–C3 level revealed hyperintensity corresponding to the right sulcal artery. Diffusion-weighted imaging revealed hyperintensities corresponding to T2 signal abnormalities, with a decreased apparent diffusion coefficient. The patient was diagnosed with cervical spinal cord infarction involving the right sulcal artery at the C2–C3 level. Subsequently, pulsed intravenous methylprednisolone and dual antiplatelet treatment (aspirin and clopidogrel) were administered. The patient showed a rapid and marked improvement in neurological function within 3 days. Conclusion: The patient in this case report initially presented with unilateral hemiparesis. The symptoms mimicked those of stroke, making accurate diagnosis challenging. This case highlights the need to consider spinal cord infarction in the differential diagnosis of patients presenting with unilateral hemiparesis. In addition, our findings suggest that spinal cord infarction may be a long-term complication in kidney transplant recipients.
- 19 March 2025
- Published by Wolters Kluwer Health in The Neurologist
- Vol. 30 (6) , 373-375
Open AccessUnilateral Weakness Caused By Spinal Cord Infarction in a Renal Transplant Recipient
Introduction: Spinal cord infarction has various clinical presentations, depending on the vascular territory involved at the spinal cord level. The most common symptom is bilateral weakness. However, unilateral hemiparesis can occur if the sulcal artery is involved. Stroke is the most common and serious cerebrovascular complication associated with kidney transplantation. Clinically asymptomatic renal transplant recipients may experience increased intima-media thickening, which is significantly associated with an increased prevalence of cerebrovascular diseases. Case Report: Herein, we report the case of a 64-year-old adult male with a history of kidney transplantation who presented with sudden-onset right-sided hemiparesis. The patient presented with right shoulder pain, right fingertip paresthesia, and recent dysuria, necessitating catheterization. T2-weighted magnetic resonance imaging at the C2–C3 level revealed hyperintensity corresponding to the right sulcal artery. Diffusion-weighted imaging revealed hyperintensities corresponding to T2 signal abnormalities, with a decreased apparent diffusion coefficient. The patient was diagnosed with cervical spinal cord infarction involving the right sulcal artery at the C2–C3 level. Subsequently, pulsed intravenous methylprednisolone and dual antiplatelet treatment (aspirin and clopidogrel) were administered. The patient showed a rapid and marked improvement in neurological function within 3 days. Conclusion: The patient in this case report initially presented with unilateral hemiparesis. The symptoms mimicked those of stroke, making accurate diagnosis challenging. This case highlights the need to consider spinal cord infarction in the differential diagnosis of patients presenting with unilateral hemiparesis. In addition, our findings suggest that spinal cord infarction may be a long-term complication in kidney transplant recipients.
- Open Access
- 31 December 2023
- Published by Korean Society of Neurosonology in Journal of Neurosonology and Neuroimaging
- Vol. 15 (2) , 75-85
The Role of Transcranial Doppler in Patients with Cryptogenic Stroke
Identifying the stroke mechanism is crucial for secondary prevention of ischemic stroke. However, approximately 20% to 30% of patients with ischemic stroke do not display a discernible cause after standard diagnostic evaluation and are classified as having cryptogenic stroke. Most cryptogenic strokes are believed to be of embolic origin, referred to as embolic stroke of undetermined source. Several potential causes, including occult atrial fibrillation, aortic arch atheroma, non-stenotic atherosclerosis, coagulopathy, and patent foramen ovale (PFO), are significant contributors to cryptogenic stroke. Among these, PFO-associated strokes often manifest as small cortical lesions in the posterior circulation and are associated with fewer traditional risk factors. Ischemic stroke is considered a high risk if there is a large PFO with significant shunting or the presence of an atrial septal aneurysm. Although transesophageal echocardiography is regarded as the gold standard for diagnosing PFO, its invasiveness, high cost, and challenges in certain stroke patients necessitate alternative approaches. Recently, transcranial Doppler (TCD) has emerged as a valuable screening tool for detecting high-risk PFOs, as supported by recent research. Accurate determination of the culprit PFO responsible for ischemic stroke remains crucial for guiding appropriate treatment decisions. This article provides a comprehensive review of the different modalities used to diagnose PFO, strategies for assessing the risk of PFO causing paradoxical embolism, and the role of TCD in patients with cryptogenic stroke caused by other etiologies.
- 31 December 2023
- Published by Korean Society of Neurosonology in Journal of Neurosonology and Neuroimaging
- Vol. 15 (2) , 75-85
Open AccessThe Role of Transcranial Doppler in Patients with Cryptogenic Stroke
Identifying the stroke mechanism is crucial for secondary prevention of ischemic stroke. However, approximately 20% to 30% of patients with ischemic stroke do not display a discernible cause after standard diagnostic evaluation and are classified as having cryptogenic stroke. Most cryptogenic strokes are believed to be of embolic origin, referred to as embolic stroke of undetermined source. Several potential causes, including occult atrial fibrillation, aortic arch atheroma, non-stenotic atherosclerosis, coagulopathy, and patent foramen ovale (PFO), are significant contributors to cryptogenic stroke. Among these, PFO-associated strokes often manifest as small cortical lesions in the posterior circulation and are associated with fewer traditional risk factors. Ischemic stroke is considered a high risk if there is a large PFO with significant shunting or the presence of an atrial septal aneurysm. Although transesophageal echocardiography is regarded as the gold standard for diagnosing PFO, its invasiveness, high cost, and challenges in certain stroke patients necessitate alternative approaches. Recently, transcranial Doppler (TCD) has emerged as a valuable screening tool for detecting high-risk PFOs, as supported by recent research. Accurate determination of the culprit PFO responsible for ischemic stroke remains crucial for guiding appropriate treatment decisions. This article provides a comprehensive review of the different modalities used to diagnose PFO, strategies for assessing the risk of PFO causing paradoxical embolism, and the role of TCD in patients with cryptogenic stroke caused by other etiologies.
- Open Access
- 1 January 2023
- Published by XMLink in Journal of Lipid and Atherosclerosis
- Vol. 12 (2) , 175-188
Low-Density Lipoprotein Cholesterol Levels Are Associated With Subsequent Stented-Territory Ischemic Stroke After Carotid Artery Stenting: A Single Center Retrospective Study
Kim SM, et al. J Lipid Atheroscler. 2023 May;12(2):175-188. https://doi.org/10.12997/jla.2023.12.2.175
- 1 January 2023
- Published by XMLink in Journal of Lipid and Atherosclerosis
- Vol. 12 (2) , 175-188
Open AccessLow-Density Lipoprotein Cholesterol Levels Are Associated With Subsequent Stented-Territory Ischemic Stroke After Carotid Artery Stenting: A Single Center Retrospective Study
Kim SM, et al. J Lipid Atheroscler. 2023 May;12(2):175-188. https://doi.org/10.12997/jla.2023.12.2.175
- Open Access
- 15 September 2022
- Published by Korean Society of Geriatric Neurology in Journal of Geriatric Neurology
- Vol. 1 (2) , 95-97
A case of transient aphasia induced by non-ketotic hyperglycemia
- 15 September 2022
- Published by Korean Society of Geriatric Neurology in Journal of Geriatric Neurology
- Vol. 1 (2) , 95-97
Open AccessA case of transient aphasia induced by non-ketotic hyperglycemia
- Open Access
- 30 April 2021
- Published by The Korean Society of Clinical Neurophysiology in Annals of Clinical Neurophysiology
- Vol. 23 (1) , 17-28
Targeting the culprit: vessel wall magnetic resonance imaging for evaluating stroke
The pathogenesis of many strokes originates in the vessel wall. Despite this, most traditional imaging focuses on the vascular lumen. Vessel-wall magnetic resonance imaging (VWMRI) is useful for establishing the etiology of intracranial stenosis. It also provides information regarding atherosclerotic plaque composition and thus plaque vulnerability, which is an indication of its potential to cause a stroke. In this review we focus on the characteristics of VWMRI findings in various arteriopathies related to intracranial artery stenosis, and discuss the clinical implications of these findings.
- 30 April 2021
- Published by The Korean Society of Clinical Neurophysiology in Annals of Clinical Neurophysiology
- Vol. 23 (1) , 17-28
Open AccessTargeting the culprit: vessel wall magnetic resonance imaging for evaluating stroke
The pathogenesis of many strokes originates in the vessel wall. Despite this, most traditional imaging focuses on the vascular lumen. Vessel-wall magnetic resonance imaging (VWMRI) is useful for establishing the etiology of intracranial stenosis. It also provides information regarding atherosclerotic plaque composition and thus plaque vulnerability, which is an indication of its potential to cause a stroke. In this review we focus on the characteristics of VWMRI findings in various arteriopathies related to intracranial artery stenosis, and discuss the clinical implications of these findings.
- 1 November 2020
- Published by Korean Neurological Association in Journal of the Korean Neurological Association
- Vol. 38 (4) , 333-335
Successful Endovascular Recanalization Therapy in a Patient with Acute Middle Cerebral Artery Occlusion and Severe Thrombocytopenia
- 1 November 2020
- Published by Korean Neurological Association in Journal of the Korean Neurological Association
- Vol. 38 (4) , 333-335
Successful Endovascular Recanalization Therapy in a Patient with Acute Middle Cerebral Artery Occlusion and Severe Thrombocytopenia